BEYFORTUS
NDC 49281-574, nirsevimab, injection, from Sanofi Vaccines US Inc..
- Product NDC
- 49281-574
- Status
- Listed
- Labeler
- Sanofi Vaccines US Inc.
- Dosage form
- INJECTION
- Route
- INTRAMUSCULAR
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761328
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/49281-574 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NIRSEVIMAB100 mg/mL
Pharmacologic classes
Fusion Protein Inhibitors [MoA]; Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 49281-574-15 | 49281057415 | 5 SYRINGE in 1 CARTON (49281-574-15) / 1 mL in 1 SYRINGE |
| 49281-574-88 | 49281057488 | 1 SYRINGE in 1 CARTON (49281-574-88) / 1 mL in 1 SYRINGE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/2f08fa60-f674-432d-801b-1f9514bd9b39
Use it
Look up 49281-574 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/49281-574 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 49281-574. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.